Mark R. Litzow, M.D.

Dr. Litzow is Professor of Medicine in the Division of Hematology at Mayo Clinic. He was the Director of the BMT Program at Mayo from 1992 to 2008 and continues to remain active in the BMT program. He was the Director of the Myeloid Disease Oriented Group in the Division of Hematology from 2002 to 2016. He was appointed chair of the Leukemia Committee of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) in September 2013 after having served as co-chair of the committee since 2001.

Dr. Litzow completed two terms as Vice-Chair for North America for the Center for International Blood and Marrow Transplant Registry (CIBMTR) and was recently appointed as a co-chair of the Acute Leukemia Working Committee of the CIBMTR. He is a member of the Board of Directors of the Foundation for the Accreditation of Cellular Therapy (FACT) and chairs the FACT Technology Committee. He just completed an 8 year term as chair of the Committee on Education for the American Society of Blood and Marrow Transplantation. His research interests include clinical trials for acute and chronic leukemia including blood and marrow transplantation and supportive care of blood and marrow transplant patients. He became board certified in Hospice and Palliative Medicine in 2013 and is a member of the Palliative Medicine Program at Mayo Clinic in Rochester. He has been awarded RO1 funding in the past for the use of autologous dendritic cell therapy for chronic myeloid leukemia. He is the author of over 480 manuscripts and multiple book chapters.